The psychedelic treatment, for PTSD, was rejected last week by government regulators...

Despite their dismal reputation, the aging painkillers are cheap and work better than nonaddictive replacements...

Many of these dead zones overlap with vulnerable communities — already poorer, sicker, and less well-resourced than the rest of the state. Where do patients go?

The Food and Drug Administration has rejected for now the first attempt to win approval of MDMA to treat post-traumatic stress disorder...

pain experienced by people with advanced disease can be prevented or relieved through optimal care, yet studies reveal that patients continue to experience uncontrolled pain the final weeks, days, and hours of their lives...

Polypharmacy is a persistent issue in elder care, particularly for patients with chronic or advanced disease...

Larger studies are under way to see if psilocybin could be a tool regularly used for palliative care, to ease the dying process...

Patients of color receive different pain care than white patients, and universities are turning to implicit bias training for clinicians and revamping medical school curricula to help fix the problem...

The number of small-chain and independent pharmacies had already been declining precipitously when Rite Aid announced late last month that it was closing hundreds of pharmacies in Ohio and Michigan...